123 related articles for article (PubMed ID: 11498080)
1. Chemiluminescence in inflammatory bowel disease patients: a parameter of inflammatory activity.
Oldenburg B; van Kats-Renaud H; Koningsberger JC; van Berge Henegouwen GP; van Asbeck BS
Clin Chim Acta; 2001 Aug; 310(2):151-6. PubMed ID: 11498080
[TBL] [Abstract][Full Text] [Related]
2. Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement?
Koek GH; Verleden GM; Evenepoel P; Rutgeerts P
Respir Med; 2002 Jul; 96(7):530-5. PubMed ID: 12194639
[TBL] [Abstract][Full Text] [Related]
3. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
4. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease.
Simmonds NJ; Allen RE; Stevens TR; Van Someren RN; Blake DR; Rampton DS
Gastroenterology; 1992 Jul; 103(1):186-96. PubMed ID: 1319369
[TBL] [Abstract][Full Text] [Related]
5. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
7. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
8. Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.
Sedghi S; Fields JZ; Klamut M; Urban G; Durkin M; Winship D; Fretland D; Olyaee M; Keshavarzian A
Gut; 1993 Sep; 34(9):1191-7. PubMed ID: 8406152
[TBL] [Abstract][Full Text] [Related]
9. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
10. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis.
Millar AD; Rampton DS; Blake DR
Aliment Pharmacol Ther; 2000 Sep; 14(9):1163-8. PubMed ID: 10971233
[TBL] [Abstract][Full Text] [Related]
11. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Zhang W; Teng G; Wu T; Tian Y; Wang H
Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
[TBL] [Abstract][Full Text] [Related]
12. Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes.
Suzuki K; Sugimura K; Hasegawa K; Yoshida K; Suzuki A; Ishizuka K; Ohtsuka K; Honma T; Narisawa R; Asakura H
Scand J Gastroenterol; 2001 Dec; 36(12):1301-6. PubMed ID: 11761021
[TBL] [Abstract][Full Text] [Related]
13. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
[TBL] [Abstract][Full Text] [Related]
14. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
15. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
16. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
[TBL] [Abstract][Full Text] [Related]
17. Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis.
Zilberman L; Maharshak N; Arbel Y; Rogowski O; Rozenblat M; Shapira I; Berliner S; Arber N; Dotan I
Digestion; 2006; 73(4):205-9. PubMed ID: 16837810
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A.
Oriishi T; Sata M; Toyonaga A; Sasaki E; Tanikawa K
Gut; 1995 Jun; 36(6):891-6. PubMed ID: 7615279
[TBL] [Abstract][Full Text] [Related]
19. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
20. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]